STEREOTAXIS INC STXS 深 滬
等待開盤 04-02 09:30:00 美东时间
1.85
+0.010
+0.54%
華盛通- 最 高1.89
- 今 開1.86
- 成交量 20.61万股
- 最 低 1.825
- 昨 收 1.84
- 總市值 1.80亿
- 52周最高 3.59
- 市盈率 靜 --
- 換手率 0.21%
- 52周最低 1.67
- 委 比 29.90%
- 總股本 9724.89万
- 歷史最高 10.30
- 量 比 0.52
- 振 幅 3.53%
- 歷史最低 1.33
- 每 手 1
- 風險率 0.40%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多STX Semiconductor Co. Files Prospectus To Offer Up To $100M In Debt, Equity, Warrants, Rights, And Units
$100,000,000 Debt SecuritiesCommon StockPreferred StockWarrantsRightsUnitsWe may offer and sell from time to time, in one or more offerings, up to $100,000,000 in the aggregate of debt securities, common stock,
03-14 04:28
Stereotaxis (STXS) Receives a Buy from TD Cowen
In a report released on March 10, Josh Jennings from TD Cowen maintained a Buy ...
03-13 01:35
Stereotaxis Q4 Earnings Summary & Key Takeaways
The earnings results for Stereotaxis (AMEX:STXS) for Q4 were made public on Mon...
03-10 04:04
Stereotaxis Q4 EPS $(0.06), Inline, Sales $8.642M Miss $9.080M Estimate
Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 33.33 percent increase over losses of $(0.09) per share from the same period last year. The
03-10 04:02
Earnings Scheduled For March 9, 2026
Companies Reporting Before The Bell • ZIM Integrated Shipping (NYSE:ZIM) is exp...
03-09 19:11
Klinikum Fürth Establishes Leading Robotic Heart Arrhythmia Program
<p>Klinikum Fürth in Germany has become the first hospital in the country to implement Stereotaxis' Genesis Robotic Magnetic Navigation System for treating arrhythmias. The system, offering precision and reduced radiation exposure, has successfully treated complex heart rhythm disorders. Dr. Laura Vitali-Serdoz and Dr. Dirk Bastian highlighted the technology's benefits, while Stereotaxis CEO David Fischel praised the partnership for expanding acc...
02-09 13:06
Stereotaxis shares are trading higher after the company announced it received FDA approval for its MAGiC Magnetic Interventional Ablation Catheter.
Stereotaxis shares are trading higher after the company announced it received F...
01-06 22:24
Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter
Stereotaxis has received FDA approval for its MAGiC Magnetic Interventional Ablation Catheter, a robotic catheter designed for minimally invasive cardiac ablation procedures. The approval marks a significant milestone in robotic cardiac ablation technology, offering enhanced precision and stability for treating complex heart rhythm disorders. The catheter is particularly beneficial for underserved patient populations with limited access to conven...
01-06 13:01
美股大行评级 | 潜在涨幅263.64%！Milestone Pharmaceuticals获富国银行升目标价至8美元，维持"超配"评级
今日重点评级关注：富国银行：维持Milestone Pharmaceuticals"超配"评级，目标价从4美元升至8美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从31美元升至33美元
2025-12-17 10:46
Citizens Initiates Coverage On Stereotaxis with Market Outperform Rating, Announces Price Target of $4
Citizens analyst Daniel Stauder initiates coverage on Stereotaxis (AMEX:STXS) with a Market Outperform rating and announces Price Target of $4.
2025-12-16 19:20
